CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Income from Cont. Operations Growth by Quarter and Year

Mateon Therapeutics Inc's Income from Cont. Operations results by quarter and year




OXGN Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.64 -3.88 -3.33
III Quarter September -0.99 -0.79 -3.96 -3.97
II Quarter June -1.19 -2.43 -3.10 -3.59
I Quarter March -0.68 -3.54 -3.64 -3.32
FY   -2.86 -7.40 -14.58 -14.21



OXGN Income from Cont. Operations third quarter 2019 Y/Y Growth Comment
Mateon Therapeutics Inc in the third quarter recorded loss from continued operations of $ -0.99 millions.

According to the results reported in the third quarter, Mateon Therapeutics Inc achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter.




OXGN Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's third quarter 2019 Income from Cont. Operations $ -0.99 millions OXGN's Income Statement
Mateon Therapeutics Inc's third quarter 2018 Income from Cont. Operations $ -0.79 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Income from Cont. Operations Growth >>


OXGN Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Mateon Therapeutics Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Mateon Therapeutics Inc in the III. Quarter 2019 admitted loss from continued operations of $ -0.99 millions, some analyst point out, that this show slight up side compare to the -1.19 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Mateon Therapeutics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's III. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Mateon Therapeutics Inc in the III. Quarter 2019 showed loss from continued operations of $ -0.99 millions, management point out, that current results point to slight up side in contrast to the -1.19 millions in the second quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Mateon Therapeutics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Mateon Therapeutics Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ -3.50 $ -3.30 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
OXGN's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for OXGN's Competitors
Income from Cont. Operations Growth for Mateon Therapeutics Inc's Suppliers
Income from Cont. Operations Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2019
Alexion Pharmaceuticals, Inc.  41.31 %$ 41.312 millions
Lhc Group, Inc  38.51 %$ 38.509 millions
Ensign Group, Inc  36.75 %$ 36.747 millions
Intuitive Surgical, Inc.  36.63 %$ 36.635 millions
Hanger, Inc.  30.26 %$ 30.259 millions
Msa Safety Inc  25.09 %$ 25.095 millions
Illumina, Inc.  24.47 %$ 24.468 millions
Biospecifics Technologies Corp  24.39 %$ 24.388 millions
United Therapeutics Corporation  24.32 %$ 24.319 millions
Medpace Holdings, inc.  24.20 %$ 24.201 millions
Edwards Lifesciences Corporation  21.60 %$ 21.602 millions
Anika Therapeutics, Inc.  21.07 %$ 21.069 millions
Lemaitre Vascular Inc  20.17 %$ 20.167 millions
China Health Industries Holdings, Inc.  19.67 %$ 19.671 millions
Conmed Corporation  19.66 %$ 19.657 millions
Idexx Laboratories Inc  16.76 %$ 16.761 millions
National Research Corporation  16.12 %$ 16.118 millions
Resmed Inc.  13.63 %$ 13.629 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AX's Profile

Stock Price

AX's Financials

Business Description

Fundamentals

Charts & Quotes

AX's News

Suppliers

AX's Competitors

Customers & Markets

Economic Indicators

AX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071